INSIGHTS ON SOLID DOSE MANUFACTURING

• Tablets And Capsules: Overcoming Similar Obstacles In Production

  Explore how understanding specific USP chapters can address common tablet and capsule production challenges and ensure high-quality results in this essential pharmaceutical process.

• How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions

  With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

• A Technology Driven CDMO & Trusted Manufacturing Partner

  Whether it's through extended release formulations or titratable dosage forms, we are dedicated to addressing the specific needs of different patient populations, including pediatrics and geriatrics.

• M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical Production

  Ensure the safety and quality of your tablets and capsules with a metal detector designed for stability and high sensitivity in pharmaceutical and nutraceutical production.

• FastLok™ Die Table Surface Overview

  10/8/2025

  Learn about a toolless, removable surface that allows for rapid, on-turret plate replacement in minutes, not weeks, significantly improving operational efficiency.

• Optimizing DPI Production: Filling Technologies For Precision And Performance

  4/16/2025

  Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.

• Modified Release Formulations: Extending Drug Commercial Lifecycle

  3/1/2024

  A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.

• Minitablets: Enhancing Safety And Palatability For Pediatric Medicines

  1/15/2026

  Leverage minitablet technology to create flexible, easy-to-swallow, and palatable pediatric formulations that improve adherence and meet evolving regulatory requirements.

• Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets

  1/27/2025

  Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.